The Current Treatment of Gastrointestinal Stromal Tumors
Dong Jianhua
Abstract
Dong Jianhua
Abstract
Gastrointestinal stromal tumors are the most common mesenchymoma.Because of the variety of their morphology and biological behavior, diagnosis and clinical treatment of gastrointestinal stromal tumors are difficult.The trait of Imatinib treatment is introduced,according to the international new development of gastrointestinal stromal tumors,in order to improve the understanding of diagnosis and clinical treatment of gastrointestinal stromal tumors.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Gastrointestinal stromal tumors are the most common mesenchymoma.Because of the variety of their morphology and biological behavior, diagnosis and clinical treatment of gastrointestinal stromal tumors are difficult.The trait of Imatinib treatment is introduced,according to the international new development of gastrointestinal stromal tumors,in order to improve the understanding of diagnosis and clinical treatment of gastrointestinal stromal tumors.
Key concepts: Stromal cell, Medicine, Imatinib, GiST, Internal medicine, Stromal tumor, Oncology, Pathology